229 related articles for article (PubMed ID: 34425892)
1. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis.
Ishiuchi N; Nakashima A; Doi S; Kanai R; Maeda S; Takahashi S; Nagao M; Masaki T
Stem Cell Res Ther; 2021 Aug; 12(1):472. PubMed ID: 34425892
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
Ishiuchi N; Nakashima A; Doi S; Yoshida K; Maeda S; Kanai R; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
Stem Cell Res Ther; 2020 Mar; 11(1):130. PubMed ID: 32197638
[TBL] [Abstract][Full Text] [Related]
3. [Effects of hypoxia-pretreated rat adipose-derived mesenchymal stem cells conditioned medium on wound healing of rats with full-thickness defects].
Gao M; Zhang J; Wang JZ; Liu Y; Zhang X; Shi Y
Zhonghua Shao Shang Za Zhi; 2020 Sep; 36(9):803-812. PubMed ID: 32972065
[No Abstract] [Full Text] [Related]
4. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis.
Yoshida K; Nakashima A; Doi S; Ueno T; Okubo T; Kawano KI; Kanawa M; Kato Y; Higashi Y; Masaki T
Stem Cells Transl Med; 2018 Dec; 7(12):893-905. PubMed ID: 30269426
[TBL] [Abstract][Full Text] [Related]
5. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects.
Kadono M; Nakashima A; Ishiuchi N; Sasaki K; Miura Y; Maeda S; Fujita A; Sasaki A; Nagamatsu S; Masaki T
Stem Cell Res Ther; 2023 Nov; 14(1):337. PubMed ID: 37993965
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis.
Nagasaki K; Nakashima A; Tamura R; Ishiuchi N; Honda K; Ueno T; Doi S; Kato Y; Masaki T
Stem Cell Res Ther; 2021 Mar; 12(1):203. PubMed ID: 33757592
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
8. Comparison of therapeutic effects of mesenchymal stem cells derived from superficial and deep subcutaneous adipose tissues.
Ishiuchi N; Nakashima A; Maeda S; Miura Y; Miyasako K; Sasaki K; Uchiki T; Sasaki A; Nagamatsu S; Nakao N; Nagao M; Masaki T
Stem Cell Res Ther; 2023 May; 14(1):121. PubMed ID: 37143086
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis.
Kanai R; Nakashima A; Doi S; Kimura T; Yoshida K; Maeda S; Ishiuchi N; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
Sci Rep; 2021 Jan; 11(1):850. PubMed ID: 33441701
[TBL] [Abstract][Full Text] [Related]
10. Secretome of Mesenchymal Stem Cells from Consecutive Hypoxic Cultures Promotes Resolution of Lung Inflammation by Reprogramming Anti-Inflammatory Macrophages.
Xu Z; Lin L; Fan Y; Huselstein C; De Isla N; He X; Chen Y; Li Y
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457151
[TBL] [Abstract][Full Text] [Related]
11. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic Preconditioning Enhances the Efficacy of Mesenchymal Stem Cells-Derived Conditioned Medium in Switching Microglia toward Anti-inflammatory Polarization in Ischemia/Reperfusion.
Yu H; Xu Z; Qu G; Wang H; Lin L; Li X; Xie X; Lei Y; He X; Chen Y; Li Y
Cell Mol Neurobiol; 2021 Apr; 41(3):505-524. PubMed ID: 32424775
[TBL] [Abstract][Full Text] [Related]
14. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
[TBL] [Abstract][Full Text] [Related]
16. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.
Takao S; Nakashima T; Masuda T; Namba M; Sakamoto S; Yamaguchi K; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takahashi S; Nakashima A; Hattori N
Stem Cell Res Ther; 2021 Sep; 12(1):506. PubMed ID: 34530920
[TBL] [Abstract][Full Text] [Related]
17. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor.
Lan YW; Theng SM; Huang TT; Choo KB; Chen CM; Kuo HP; Chong KY
Stem Cells Transl Med; 2017 Mar; 6(3):1006-1017. PubMed ID: 28297588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
